50mg Cephacare Flavour Tablet - per Tablet

Description

50mg Cephacare may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase 50mg Cephacare if you have or are in the process of arranging such a prescription. See information bar for further details.  

50mg Cephacare Flavour Tablet

Cephacare Flavour 50mg Beef flavoured beige round biconvex tablets with a break mark on one side. Each tablet contains 50mg cefalexin (as monohydrate). Indicated for cats and dogs. Cephacare Flavour 250mg Beef flavoured beige flat tablets with a break mark on one side. Each tablet contains 250mg cefalexin (as monohydrate). Indicated for dogs. Cephacare Flavour 500mg Beef flavoured beige flat tablets with a break mark on one side. Each tablet contains 500mg cefalexin (as monohydrate). Indicated for dogs.

50mg Cephacare is a semi-synthetic bactericidal antibiotic belonging to the cephalosporin group which acts by interference with bacterial cell wall formation. 50mg Cephacare is active against a wide range of Gram-positive and Gram-negative bacteria. The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp (including penicillin-resistant strains) Streptococcus spp Corynebacterium spp Pasteurella multocida Escherichia coli Micrococcus spp Moraxella spp. Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase. 50mg Cephacare is also active against the majority of ampicillin-resistant E.coli. Indications in dogs Treatment of infections of the respiratory tract gastro-intestinal tract urogenital tract the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin. Indications in cats Treatment of infections of the respiratory tract urogenital tract the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin.

Dosage and administration
For oral administration. 50mg Cephacare flavour tablets have a break mark on one side. To enable more accurate dosing half tablets may be used as necessary. Tablets may also be added to food if necessary. To avoid underdosing the bodyweight should be accurately determined. Dogs A dose of 15 mg/kg twice daily is recommended to be doubled where appropriate. Treatment for five days is recommended. Any increase in dose or duration of use should be according to a risk/benefit assessment by the prescribing veterinarian (e.g. in cases of chronic pyoderma). Cats A dose of 15 mg/kg twice daily for 5 days is recommended.

Contra-indications warnings etc
For animal treatment only. Use of 50mg Cephacare should be based on susceptibility testing and take into account official and local antimicrobial policies. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins due to the potential for cross resistance. In the case of an allergic reaction treatment should be withdrawn. The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate. As with other antibiotics which are excreted mainly by the kidneys unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian. The safety of the product has not been demonstrated in studies in pregnant or lactating dogs and cats. Use only in accordance with a risk/benefit assessment by the responsible veterinarian. Transient episodes of soft faeces and vomiting have been observed in cats when given products containing cefalexin. Treatment should be discontinued if vomiting and diarrhoea develop. Vomiting has been observed occasionally in dogs when given products containing cefalexin. Contraindications Do not use 50mg Cephacare in cases of known hypersensitivity to the active substance to other cephalosporins to other substances of the b-lactam group or to any of the excipients. Do not use 50mg Cephacare in rabbits gerbils guinea pigs and hamsters. User warnings Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection inhalation ingestion or skin contact. Hypersensitivity to penicillin may lead to cross-reactions to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to be in contact with such substances. Handle this product with great care to avoid exposure taking all recommended precautions. If you develop symptoms following exposure such as skin rash you should seek medical advice and show the doctor this warning. Swelling of the face lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician. Wash hands after use.   Pharmaceutical precautions Return any tablet to the blister pack and use within 24 hours. Keep the blister pack in the outer carton. Keep out of the reach and sight of children. Do not store 50mg Cephacare above 25C. Store 50mg Cephacare in a dry place. Do not use after the expiry date stated on blister and carton. Disposal Any unused product or waste materials should be disposed of in accordance with national requirements.

Legal category
50mg Cephacare is a POM-V (Pet Prescription Required)